Press releases
- AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
- AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
- AbCellera Reports Q1 2024 Business Results
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
Key statistics
On Friday, Abcellera Biologics Inc (8QQ:FRA) closed at 2.43, 0.00% above its 52-week low of 2.43, set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.43 |
---|---|
High | 2.43 |
Low | 2.43 |
Bid | 2.46 |
Offer | 2.51 |
Previous close | 2.44 |
Average volume | 1.44k |
---|---|
Shares outstanding | 294.05m |
Free float | 211.69m |
P/E (TTM) | -- |
Market cap | 791.01m USD |
EPS (TTM) | -0.5056 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 07:01 BST.
More ▼